APA (7th ed.) Citation

McDonnell, A., Collins, S., Ali, Z., Iavarone, L., Surujbally, R., Kirby, S., & Butt, R. P. (2018). Efficacy of the Nav1.7 blocker PF-05089771 in a randomised, placebo-controlled, double-blind clinical study in subjects with painful diabetic peripheral neuropathy. Pain (Amsterdam), 159(8), 1465. https://doi.org/10.1097/j.pain.0000000000001227

Chicago Style (17th ed.) Citation

McDonnell, Aoibhinn, Susie Collins, Zahid Ali, Laura Iavarone, Raulin Surujbally, Simon Kirby, and Richard P. Butt. "Efficacy of the Nav1.7 Blocker PF-05089771 in a Randomised, Placebo-controlled, Double-blind Clinical Study in Subjects with Painful Diabetic Peripheral Neuropathy." Pain (Amsterdam) 159, no. 8 (2018): 1465. https://doi.org/10.1097/j.pain.0000000000001227.

MLA (9th ed.) Citation

McDonnell, Aoibhinn, et al. "Efficacy of the Nav1.7 Blocker PF-05089771 in a Randomised, Placebo-controlled, Double-blind Clinical Study in Subjects with Painful Diabetic Peripheral Neuropathy." Pain (Amsterdam), vol. 159, no. 8, 2018, p. 1465, https://doi.org/10.1097/j.pain.0000000000001227.